Jove
Visualize
Contact Us

Related Experiment Videos

Surfactant gene polymorphisms and interstitial lung diseases.

Panagiotis Pantelidis1, Srihari Veeraraghavan, Roland M du Bois

  • 1Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, Imperial College of Science, Technology and Medicine, National Heart and Lung Institute, & Royal Brompton Hospital, London, UK. s.veeraraghavan@ic.ac.uk

Respiratory Research
|January 25, 2002
PubMed
Summary

Pulmonary surfactant, vital for lung function, shows altered composition in interstitial lung diseases (ILDs). Genetic mutations affecting surfactant protein C are linked to familial ILD, increasing research interest.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thoracic and Cardiovascular Imaging Manifestations of Lupus.

Radiographics : a review publication of the Radiological Society of North America, Inc·2024
Same author

Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis.

BMC pulmonary medicine·2024
Same author

Pulmonary hypertension mortality trends in United States 1999-2019.

Annals of epidemiology·2022
Same author

Variability in detection of SARS-CoV-2-specific antibody responses following mild infection: a prospective multicentre cross-sectional study, London, United Kingdom, 17 April to 17 July 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2022
Same author

Rapid design and implementation of an adaptive pooling workflow for SARS-CoV-2 testing in an NHS diagnostic laboratory: a proof-of-concept study.

Wellcome open research·2021
Same author

An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis.

ERJ open research·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pulmonary medicine
  • Biochemistry
  • Genetics

Background:

  • Pulmonary surfactant, a mix of phospholipids and proteins in alveolar fluid, is crucial for lung function.
  • Abnormalities in surfactant composition are observed in various interstitial lung diseases (ILDs).

Purpose of the Study:

  • To highlight the growing attention on the role of pulmonary surfactant in lung diseases.
  • To underscore the significance of genetic factors in surfactant protein expression and ILD development.

Main Methods:

  • Review of existing literature on pulmonary surfactant composition and function.
  • Analysis of studies linking surfactant protein gene mutations to familial ILD.
  • Examination of evidence for surfactant abnormalities in interstitial lung diseases.

Related Experiment Videos

Main Results:

  • Alterations in surfactant composition are a feature of several ILDs.
  • A mutation in the surfactant protein C gene, causing protein absence, is associated with familial ILD.

Conclusions:

  • The genetic basis of surfactant protein expression and observed surfactant abnormalities in ILD warrant increased research focus.
  • Pulmonary surfactant's role in lung disease pathogenesis is increasingly recognized, particularly in familial forms.